To define the functional significance of the expression of BRG1 in differentiated GBM cells grown in vitro, we used CRISPR/Cas9 lentivirus encoding three different gRNAs to delete the BRG1 gene from LN229 and MT330 GBM cells. The gene discussed is SMARCA4; the disease is glioblastoma.